Related Experiment Video
Updated: Jul 18, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Sugihiratake mushroom (angel's wing mushroom)-induced cryptogenic encephalopathy may involve vitamin D analogues
Hideki Sasaki1, Hiroshi Akiyama, Yoshifumi Yoshida
1Nihon Waters K.K., Tokyo, Japan. hideki_sasaki@waters.com
Abstract:
In autumn 2004, many Japanese patients with renal failure developed cryptogenic encephalopathy by consuming sugihiratake mushroom, a Japanese delicacy. To elucidate the relationship between the cryptogenic cases and this mushroom, we conducted a multivariate analysis of metabolites in 'Probably Toxic' sugihiratake collected from the area of encephalopathy outbreaks, and 'Probably Safe' sugihiratake collected from unaffected areas using UPLC/ToF MS. The results indicate that the presence of milligram quantities of vitamin D-like compounds per 10 g of dried sugihiratake from the areas of encephalopathy outbreaks. Two hypotheses to induce the encephalopathy are proposed: the found metabolites are (1) vitamin D agonists, which induce acute and severe hypercalcemia and/or hyperammonemia and/or vitamin D toxicity, or (2) vitamin D antagonists, which induce acute and severe hypocalcemia.
Insights
Sugihiratake mushroom consumption was linked to a 2004 Japanese outbreak of cryptogenic encephalopathy. Analysis revealed vitamin D-like compounds in toxic mushrooms, potentially causing severe hypercalcemia or hypocalcemia.
Area of Science:
- Food safety
- Toxicology
- Neuroscience
Background:
- In 2004, a Japanese outbreak of cryptogenic encephalopathy occurred among renal failure patients.
- Mushroom consumption, specifically sugihiratake, was implicated in the outbreak.
Purpose of the Study:
- To investigate the link between sugihiratake mushroom consumption and cryptogenic encephalopathy.
- To identify potential toxic metabolites in sugihiratake mushrooms.
Main Methods:
- Multivariate analysis of metabolites using UPLC/ToF MS.
- Comparison of 'Probably Toxic' and 'Probably Safe' sugihiratake samples.
Main Results:
- Milligram quantities of vitamin D-like compounds were detected in toxic sugihiratake.
- These compounds were present in mushrooms from outbreak areas.
Conclusions:
- The identified vitamin D-like compounds may cause encephalopathy via vitamin D agonism (hypercalcemia/hyperammonemia) or antagonism (hypocalcemia).
- Further research is needed to confirm the exact mechanism of toxicity.
Related Concept Videos
Cryptococcal Meningitis
Encephalitis l: Introduction
Vitamins
Hepatic Encephalopathy
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
